276 related articles for article (PubMed ID: 28298856)
1. Applications of polymers in intraocular drug delivery systems.
Alhalafi AM
Oman J Ophthalmol; 2017; 10(1):3-8. PubMed ID: 28298856
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor Drugs.
Sun Z; Duan R; Xing D; Pang X; Li Z; Chen X
Curr Cancer Drug Targets; 2017; 17(5):445-455. PubMed ID: 28067177
[TBL] [Abstract][Full Text] [Related]
3. Hydrogels in ophthalmic applications.
Kirchhof S; Goepferich AM; Brandl FP
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):227-38. PubMed ID: 26032290
[TBL] [Abstract][Full Text] [Related]
4. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
[TBL] [Abstract][Full Text] [Related]
5. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical, biomedical and ophthalmic applications of biodegradable polymers (BDPs): literature and patent review.
Osi B; Khoder M; Al-Kinani AA; Alany RG
Pharm Dev Technol; 2022 Mar; 27(3):341-356. PubMed ID: 35297285
[TBL] [Abstract][Full Text] [Related]
7. Bioerodible polymers for ocular drug delivery.
Deshpande AA; Heller J; Gurny R
Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417
[TBL] [Abstract][Full Text] [Related]
8. Dendrimeric systems and their applications in ocular drug delivery.
Yavuz B; Pehlivan SB; Unlü N
ScientificWorldJournal; 2013; 2013():732340. PubMed ID: 24396306
[TBL] [Abstract][Full Text] [Related]
9. [Drug delivery systems for the posterior segment of the eye: fundamental basis and applications].
Fialho SL; Cunha Júnior Ada S
Arq Bras Oftalmol; 2007; 70(1):173-9. PubMed ID: 17505743
[TBL] [Abstract][Full Text] [Related]
10. Implantable controlled release systems.
Langer R
Pharmacol Ther; 1983; 21(1):35-51. PubMed ID: 6353438
[TBL] [Abstract][Full Text] [Related]
11. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
Wu KY; Joly-Chevrier M; Akbar D; Tran SD
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111579
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
Bisht R; Jaiswal JK; Rupenthal ID
Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
[TBL] [Abstract][Full Text] [Related]
13. Thermosensitive polymeric hydrogels as drug delivery systems.
Gong C; Qi T; Wei X; Qu Y; Wu Q; Luo F; Qian Z
Curr Med Chem; 2013; 20(1):79-94. PubMed ID: 23092130
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive review of the role of acrylic acid derivative polymers in floating drug delivery system.
Kumari B; Khansili A; Phougat P; Kumar M
Polim Med; 2019; 49(2):71-79. PubMed ID: 32589822
[TBL] [Abstract][Full Text] [Related]
15. Preparation of dexamethasone ophthalmic implants: a comparative study of in vitro release profiles.
Prata AI; Coimbra P; Pina ME
Pharm Dev Technol; 2018 Mar; 23(3):218-224. PubMed ID: 28300463
[TBL] [Abstract][Full Text] [Related]
16. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
17. Considerations for Polymers Used in Ocular Drug Delivery.
Allyn MM; Luo RH; Hellwarth EB; Swindle-Reilly KE
Front Med (Lausanne); 2021; 8():787644. PubMed ID: 35155469
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic gels: Past, present and future.
Al-Kinani AA; Zidan G; Elsaid N; Seyfoddin A; Alani AWG; Alany RG
Adv Drug Deliv Rev; 2018 Feb; 126():113-126. PubMed ID: 29288733
[TBL] [Abstract][Full Text] [Related]
20. Long-term release of fluocinolone acetonide using biodegradable fumarate-based polymers.
Haesslein A; Ueda H; Hacker MC; Jo S; Ammon DM; Borazjani RN; Kunzler JF; Salamone JC; Mikos AG
J Control Release; 2006 Aug; 114(2):251-60. PubMed ID: 16872709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
